Literature DB >> 8432162

Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients.

M Sonnenblick1, Y Friedlander, A J Rosin.   

Abstract

Thiazides were responsible for severe diuretic-induced hyponatremia (serum sodium level < 115 mEq/L) in 94 percent of 129 cases reported in the literature between 1962 and 1990. The hyponatremia developed within 14 days in most of the patients receiving thiazides but in none of the patients who were treated with furosemide. Diuretic-induced hyponatremia was four times more common in women than in men. Advanced age was not associated with a higher tendency for hyponatremia. In the majority of the patients who received thiazides, excess antidiuretic hormone activity, hypokalemia, and excess water intake were accompanying findings which, singly or together, appeared to contribute to the development of hyponatremia. In 12 patients, mortality was directly related to hyponatremia. Rapid average correction of hyponatremia and a relatively high total correction (over 20 mEq/L) in the first 24 h were significantly associated with higher mortality or demyelinating syndrome. The presence of neurologic signs is an indication for active sodium replacement. The onset of thiazide-induced hyponatremia may in some cases occur within 1 day and therefore needs to be corrected rapidly, but within a total elevation of 20 mEq/L in the first 24 h. Where the onset is judged to have been slow (over several days), the level should be corrected at a slow rate, up to a total of 12 to 15 mEq/L in 24 h.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432162     DOI: 10.1378/chest.103.2.601

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  52 in total

1.  Hyponatremic encephalopathy induced by thiazides.

Authors:  J Al-Salman; R Pursell
Journal:  West J Med       Date:  2001-08

Review 2.  Hyponatremia.

Authors:  Jameela Al-Salman; David Kemp; Daniel Randall
Journal:  West J Med       Date:  2002-05

3.  Association between antidepressant drug use and hyponatraemia: a case-control study.

Authors:  Kris L L Movig; Hubert G M Leufkens; Albert W Lenderink; Veronique G A van den Akker; Paul P G Hodiamont; Henk M J Goldschmidt; Antoine C G Egberts
Journal:  Br J Clin Pharmacol       Date:  2002-04       Impact factor: 4.335

4.  Clinical studies of thiazide-induced hyponatremia.

Authors:  Kai Ming Chow; Bonnie Ching-Ha Kwan; Cheuk Chun Szeto
Journal:  J Natl Med Assoc       Date:  2004-10       Impact factor: 1.798

5.  Heritability of serum sodium concentration: evidence for sex- and ethnic-specific effects.

Authors:  Beth Wilmot; V Saroja Voruganti; Yen-Pei C Chang; Yi Fu; Zhan Chen; Herman A Taylor; James G Wilson; Teresa Gipson; Vallabh O Shah; Jason G Umans; Michael F Flessner; Robert Hitzemann; Alan R Shuldiner; Anthony G Comuzzie; Shannon McWeeney; Philip G Zager; Jean W Maccluer; Shelley A Cole; David M Cohen
Journal:  Physiol Genomics       Date:  2011-12-20       Impact factor: 3.107

6.  Thiazide diuretic prescription and electrolyte abnormalities in primary care.

Authors:  J A Clayton; S Rodgers; J Blakey; A Avery; I P Hall
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

7.  Severe Symptomatic Diuretic Induced Hyponatremia.

Authors:  M K Garg; V Nair; N Kumar
Journal:  Med J Armed Forces India       Date:  2011-07-21

8.  Syndrome of inappropriate antidiuretic hormone secretion (SIADH) or hyponatraemia associated with valproic Acid: four case reports from the Netherlands and a case/non-case analysis of vigibase.

Authors:  Erna Beers; Eugène P van Puijenbroek; Imke H Bartelink; Carolien M J van der Linden; Paul A F Jansen
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

Review 9.  Loop Diuretics in the Treatment of Hypertension.

Authors:  Line Malha; Samuel J Mann
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

10.  Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome.

Authors:  Vildan Tasdemir; Ali Kemal Oguz; Irmak Sayın; Ihsan Ergun
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.